Phenylpropanolamine

This classification denotes an adrenergic agonist with the molecular formula C9H13NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33RU150WUN, chemically known as 1r,2s-(-)-norephedrine hydrochloride but generally known as phenylpropanolamine, which bears US NIH Compound Identifier 4786. European Medicines Agency schedules Phenylpropanolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09790MIG. The term PHENYLPROPANOLAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules phenylpropanolamine in its Anatomical Therapeutic Chemical (ATC) Classification. PHENYLPROPANOLAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phenylpropanolamine under HS 29394900 and SITC 54144. As of Q4 2014, PHENYLPROPANOLAMINE remains the US FDA Preferred Term for this commodity. Phenylpropanolamine bears US NLM identifiers UMLS ID C0031495 and NCI Concept Code C29364. SMILES: OC(C(N)C)C1CCCCC1.